Article metrics

Download PDFPDF

679 Characterization of tumor specific CD8+ T cell responses in patients with recurrent/metastatic HPV16-positive head and neck cancer receiving HB-200 monotherapy as second or later line treatment in a phase 1 study

 

Online download statistics by month:

Online download statistics by month: November 2023 to January 2024

AbstractFullPdf
Nov 2023292018
Dec 202368014
Jan 20248909
Total449041